Follow The Filings

RKDA Arcadia Biosciences

Arcadia Biosciences earnings company data as of 12:01 PM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -2.09 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 5.02,5.07,9.01
8-K 3.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
DEF 14A
8-K 3.01,9.01
424B3
8-K 5.02,5.08,8.01
8-K 1.01,3.02,7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
10-K/A
8-K 4.01,9.01
8-K 2.02,9.01
10-K
424B3
8-K 5.02,9.01
8-K 1.01,3.02,3.03,7.01,9.01
8-K 1.02,7.01,9.01
8-K 5.07
DEF 14A
8-K 2.02,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Sep 10, 2026 (4 forms)
4 Period May 9, 2025

1 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.